que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.

Author: JoJotaxe Kajigul
Country: Montserrat
Language: English (Spanish)
Genre: Technology
Published (Last): 19 December 2008
Pages: 416
PDF File Size: 19.45 Mb
ePub File Size: 13.89 Mb
ISBN: 329-6-23849-301-8
Downloads: 2976
Price: Free* [*Free Regsitration Required]
Uploader: Moogur

Resultados negativos asociados al uso de medicamentos que motivan ingreso hospitalario.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica

The outcomes of the pharmaceutical interventions in the study were statistically analyzed with the STATA program version Upon changes in medication, a new condition status was established, which also evaluated the acceptance or non-acceptance of the physician’s pharmaceutical recommendations. Mezzano S, Aros C. Like a snake in the grass. Analysis per healthcare insurance carrier revealed that the difference in the mean ratio of the direct cost farmacoterapeutivo in the range of 1.

It is worth mentioning that in the study carried out, there was an important loss of patients Results In total, 47 patients accepted to enter the Famracoterapeutico program; 21 of them were men and 26 were women.

It was calculated that the among the main antidiabetic medications consumed [Defined Daily Dose DDD ] glibenclamide represented 0.

The medications with one single case were clobazam, ceftriaxone and dexamethasone. This differs from the study by Alviz et al. The intervention was not accepted farmacoterapeuticoo the health problem was not solved during the first visit in 67 patients On the other hand, there was an increase in the haemoglobin levels in the optimal group.

Expanding the roles of outpatient pharmacists: The study was conveniently conducted in these cities because there was trained personnel for said purpose. This study presented a series of difficulties worth describing because they may be useful for those who may implement pharmacotherapeutic monitoring, such as: This highlights the importance of this public health problem and its major clinical, social and economic impact, associated with Chronic Kidney Disease; therefore, it is necessary to involve all health professionals seguimirnto patients, to obtain as a result a better use of medications, the prevention of NOMs and a reduction in morbidity associated with pharmacotherapy.


Necessity NOMs, when patients are not receiving an adequate treatment for their condition, and the other cause is that the health problems of patients are not receiving treatment; Effectiveness NOMs, when the treatment does not meet the therapeutical objectives, based diabftes the dose administered; and Safety NOMs, identified when health problems develop as a consequence of drug therapy, which can be dose-dependent or not.

The authors manifest and declare having no conflict of interest. The finding of a high percentage of ineffectiveness NOM Along with other studies, during the initial interview, we found co-morbidities frequently associated sobfe diabetes, such as hypertension That is why Pharmaceutical Care should include SOPs structured by criteria reached by consensus to conduct Pharmaceutical Care Practice, which will enable to prevent, identify and solve any negative outcomes in patients that are associated with medication.

Effectiveness NOMS were those with the highest proportion. The status of the condition was also elaborated for this group and a final visit was conducted; thereby, detecting the NOM.

This shows the importance of this public health problem, and its major clinical, social and economic consequences, which are associated with Chronic Kidney Disease.

In terms of ethnicity, 13 patients were white, 5 patients were black, and 29 were of mixed race. These findings suggest that the active involvement of Pharmacists in the treatment of renal anaemia for patients under diaebtes had a great therapeutic impact. No important differences were found with the control group.

To learn about the types of problems related to medications and negative outcomes associated with drugs that can be detected, prevented and solved in patients with chronic kidney disease, through pharmaceutical care practice.

Phone calls and visits were also made every four months to inquire about hospitalizations, visits to the general physician, specialist, and emergency services.

In total, 47 patients accepted to enter the PCP program; 21 of them were men and 26 were women. Therefore, the Pharmacist, as a medication professional, can offer interventions that will benefit the health and wellbeing of patients with CKD.

The most prevalent co-morbidities were hypertension, dislipidemia, and hypothyroidism and the most frequent long-term complications can be seen in Table 2.

Solution of negative outcomes associated with medication. This finding warrants conducting a more profound study of the impact expected of pharmacotherapeutic monitoring on the cost of healthcare.


Seguimiento farmacoterapéutico en pacientes con insuficiencia renal crónica

The inability by patients to excrete drugs that are eliminated through the kidneys can lead to a build-up or metabolites, in case of repeated administration. To determine the effectiveness of pharmaceutical care to improve control of type-2 diabetes mellitus.

Quality of diabetes care in US academic medical centers: Additionally, we conducted an analysis of the increasing cost-effectiveness ratios for each EPS.

Diabetes mellitus; Glucosylated hemoglobin A; Hypoglycemic agents; Pharmaceutical services; Colombia. Adis Internacional Limited, This is an open-access article distributed under the terms of the Creative Commons Attribution License. Guix with type-2 farmacotetapeutico mellitus, affiliated to the contributive regime of two Farmacotera;eutico, who had continuity in antidiabetic treatment in the three months prior, defined by attendance to medical control and request for dispensing of normoglycemiant medication; these patients were over 18 years of age and accepted to participate in the study.

Because the statistics for hypothesis tests were not significant, we opted for a bivariate analysis for the quantitative parameters via hazard ratios. The mean cost per patient in controls was 1. Increased effectiveness of the antidiabetic sguimiento was not demonstrated in patients intervened with pharmacotherapeutical monitoring, but we did obtain a reduction in healthcare costs.

On the other hand, hypertension and DM are the most important risk factors that lead to deterioration in renal function, because the kidney is one of the target organs in these conditions; at the same time, together they will increase the cardiovascular risk 22 It was noted that the mean ratio average per patient for the patients in the control group was 1.

C, Navarro Ruiz A. Some treating physicians do not follow the guidelines for treatment of diabetes mellitus and do not make opportune requests for paraclinical and medical exams necessary for the complete analysis in pharmacotherapeutical monitoring. All these problems were detected and solved, pharmaceutical interventions were conducted verbally and in writing, with the aim of helping to improve the quality of farmacotrapeutico of patients, and therefore prevent farmacotetapeutico development.

Stemer G, Lemmens G.